Clinical Trials Logo

Terlipressin Adverse Reaction clinical trials

View clinical trials related to Terlipressin Adverse Reaction.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT04221672 Recruiting - Acute Kidney Injury Clinical Trials

The Effect of Terlipressin on Recovery of Liver Function After Hepatectomy

Start date: November 7, 2019
Phase: Phase 3
Study type: Interventional

Portal vein hypertension is associated with post-hepatectomy liver failure in patients with liver cirrhosis. Our previous study found that bolus injection of 1 mg terlipressin immediately after hepatectomy decreased portal vein pressure, and post-operative continuous use of terlipressin decreased the amount of abdominal drain. In this multicenter randomized controlled study, we aim to evaluate the effects of terlipressin in the patients who underwent liver resection complicated by portal vein hypertension.

NCT ID: NCT04028505 Recruiting - Clinical trials for Terlipressin Adverse Reaction

Terlipressin Infusion in Variceal Hemorrhage

TT
Start date: October 25, 2018
Phase: Phase 3
Study type: Interventional

Randomized, open label study of intravenous terlipressin infusion vs. bolus for the treatment of variceal hemorrhage. 24 hour regimen consisting of intravenous terlipressin will be used either at a rate of 0.5mg/hour or 2mg bolus every 4 hourly. Participants will be randomized into intervention and control arm using block randomization by computer generated random numbers. Efficacy will be assessed by clinical improvement in symptoms and signs of GI bleed. To assess safety, frequency and degree of adverse reactions will be observed. Periodic assessments until 5 days will be done consisting of physical examination, safety assessments, vital signs and lab tests.